FdaApplication
NDA 050596
Identifiers
- fda_app_no: NDA050596
Properties
| Property | Value |
|---|---|
| applicant_name | STERIMAX INC |
| application_type | NDA |
| approval_date | 1985-05-20 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER | CEFOTAXIME SODIUM | EQ 20MG BASE/ML | INJECTABLE;INJECTION |
| CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER | CEFOTAXIME SODIUM | EQ 40MG BASE/ML | INJECTABLE;INJECTION |
| CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | CEFOTAXIME SODIUM | EQ 40MG BASE/ML | INJECTABLE;INJECTION |
| CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | CEFOTAXIME SODIUM | EQ 20MG BASE/ML | INJECTABLE;INJECTION |
4 products